HTRA1 and non-small cell lung carcinoma: The combination of the HDAC inhibitors and Bexa significantly up-regulated HtrA1 expression compared to the control and single-compound groups in CDDP resistant NSCLC cells (Fig. 2c, and Fig. S2C), as well as parental cells (Fig. S2D-E).